| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 211.71B | 210.84B | 236.49B | 226.17B | 167.79B | 289.28B |
| Gross Profit | 23.95B | 26.03B | 29.61B | 27.26B | 20.25B | 16.22B |
| EBITDA | 7.96B | 10.15B | 9.98B | 10.60B | 4.91B | -1.39B |
| Net Income | 2.94B | 4.27B | 3.40B | 5.20B | 2.44B | -2.13B |
Balance Sheet | ||||||
| Total Assets | 138.60B | 144.76B | 174.12B | 176.00B | 148.18B | 127.56B |
| Cash, Cash Equivalents and Short-Term Investments | 24.32B | 24.25B | 23.82B | 21.25B | 25.25B | 26.87B |
| Total Debt | 49.46B | 50.53B | 64.71B | 74.64B | 53.93B | 47.47B |
| Total Liabilities | 78.97B | 84.26B | 117.68B | 122.91B | 100.60B | 82.52B |
| Stockholders Equity | 53.84B | 54.52B | 50.70B | 47.75B | 42.71B | 40.02B |
Cash Flow | ||||||
| Free Cash Flow | 28.62B | 17.18B | 21.52B | -19.25B | -3.69B | 14.66B |
| Operating Cash Flow | 30.15B | 18.62B | 22.69B | -18.98B | -2.95B | 15.21B |
| Investing Cash Flow | -1.90B | -2.15B | -1.42B | -326.00M | 145.00M | -790.00M |
| Financing Cash Flow | -27.11B | -16.41B | -20.05B | 14.07B | 391.00M | -8.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥185.59B | 4.98 | 17.09% | 2.94% | 9.67% | 45.58% | |
76 Outperform | ¥22.01B | 10.49 | ― | 3.83% | 41.87% | 167.99% | |
74 Outperform | ¥49.00B | 13.51 | ― | 4.12% | -4.88% | -26.05% | |
65 Neutral | ¥28.72B | -17.27 | ― | 5.16% | 1.71% | -29.37% | |
64 Neutral | ¥13.89B | 25.64 | ― | 4.62% | -2.98% | 4.56% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥31.90B | 40.99 | 1.55% | 1.34% | -34.13% | -31.24% |